BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
303 hedge funds and large institutions have $9B invested in bluebird bio in 2018 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 93 increasing their positions, 113 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $9.26B → $9B (-$260M)
18% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 113
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
303
Holding in Top 10
2
Calls
$185M
Puts
$168M
Top Buyers
| 1 | +$174M | |
| 2 | +$64.5M | |
| 3 | +$56.9M | |
| 4 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
+$49.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$46.7M |
Top Sellers
| 1 | -$52.9M | |
| 2 | -$52.1M | |
| 3 | -$51M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$47.3M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$39.5M |